3,279 reports of this reaction
3.3% of all CONJUGATED ESTROGENS reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for CONJUGATED ESTROGENS, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. There are 3,279 FDA adverse event reports linking CONJUGATED ESTROGENS to DRUG INEFFECTIVE. This represents approximately 3.3% of all 100,524 adverse event reports for this drug.
Patients taking CONJUGATED ESTROGENS who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among CONJUGATED ESTROGENS users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for CONJUGATED ESTROGENS:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 3,279 FDA reports for CONJUGATED ESTROGENS. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.3% of all adverse event reports for CONJUGATED ESTROGENS, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking CONJUGATED ESTROGENS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.